EvoNext Holdings SA (SWX:EVE)
Switzerland · Delayed Price · Currency is CHF 0.8600
+0.0400 (4.88%)
At close: Jan 30, 2026
EvoNext Holdings Market Cap
EvoNext Holdings has a market cap or net worth of 6.2 million as of January 30, 2026. Its market cap has decreased by -15.69% in one year.
Market Cap
6.20M
Enterprise Value
-111.07K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.86
Market Cap Chart
Since March 1, 2010, EvoNext Holdings's market cap has decreased from 392.12M to 6.20M, a decrease of -98.42%. That is a compound annual growth rate of -22.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 6.20M | 6.17% |
| Dec 30, 2025 | 5.84M | -10.00% |
| Dec 30, 2024 | 6.49M | 32.37% |
| Dec 29, 2023 | 4.90M | -94.61% |
| Dec 30, 2022 | 91.05M | -28.31% |
| Dec 30, 2021 | 127.00M | -19.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 913.93M |
| Basilea Pharmaceutica AG | 684.45M |
| Newron Pharmaceuticals | 405.30M |
| Santhera Pharmaceuticals Holding AG | 181.83M |
| BioVersys AG | 142.69M |
| Xlife Sciences AG | 135.54M |
| Molecular Partners AG | 114.82M |
| Addex Therapeutics | 6.34M |